The objective of this study was to assess the effects of pharmaceutical care process
provided to obese schizophrenic patients. Parameters used to evaluate the effectiveness of …

Aims: Weight gain secondary to antipsychotic medication is associated with many serious
conditions, including type II diabetes mellitus, hypertension, and coronary heart disease …

Background: Atypical antipsychotics offer clear advantages in the management of
schizophrenia, compared with conventional neuroleptics, but weight gain is a significant …

Objective: The presence of obesity and increases in body mass are important risk factors for
cardiovascular disease and diabetes. This study examined the effects of olanzapine …

Methods Individuals with schizophrenia suffer increased rates of obesity compared to the
general population. Weight gain can be induced by treatment with antipsychotic …

Objective: To investigate the effects of risperidone and clozapine on blood glucose and lipid
metabolism in patients with schizophrenia. Methods: 70 cases of first-episode schizophrenia …

From the Department of Psychiatry, Vanderbilt University School of Medicine, Nashville,
Tenn.(Dr. Meltzer); and the Department of Biological Psychiatry, Innsbruck University Clinics …

Obesity is common in schizophrenia, and people with schizophrenia appear to be at
increased risk for certain obesity-related conditions, such as type 2 diabetes and …

Sex differences in schizophrenia have been well recognized. However, sex differences in
obesity associated with antipsychotics have received little systematic study. This study was …